# Safety and Immunogenicity of Coadministration of the Candidate Rabies Vaccine ChAdOx2 RabG and Licensed Vaccine

> **NCT07168018** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Oxford** · enrollment: 40 (estimated)

## Conditions studied

- Rabies

## Interventions

- **BIOLOGICAL:** Coadministration of ChAdOx2 RabG and licensed inactivated rabies vaccine (IRV)
- **BIOLOGICAL:** Inactivated Rabies Vaccine (IRV)

## Key facts

- **NCT ID:** NCT07168018
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07168018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07168018, "Safety and Immunogenicity of Coadministration of the Candidate Rabies Vaccine ChAdOx2 RabG and Licensed Vaccine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07168018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*